WHAT IS BEXSERO (Meningococcal Group B Vaccine)?
BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.
Approval of BEXSERO is based on demonstration of immune response against three serogroup B strains representative of prevalent strains in the United States. The effectiveness of BEXSERO against diverse serogroup B strains has not been confirmed.
BEXSERO may not protect all vaccine recipients.
BEXSERO is a 2-dose vaccine series given in the muscle of the upper arm. The second dose should be given at least one month after the first dose.
It is important to receive both doses.
Patients must receive the same vaccine product for all doses.
WHO SHOULD NOT GET BEXSERO
- People should not get BEXSERO if they have had a severe allergic reaction to any ingredient of BEXSERO or after a previous dose of BEXSERO
WARNINGS AND PRECAUTIONS
- The tip caps of the syringe for BEXSERO contain natural rubber latex, which may cause allergic reactions
- Fainting can occur after receiving BEXSERO. For this reason, your healthcare professional may ask you to sit or lie down for 15 minutes after receiving BEXSERO
- Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
- Individuals with certain complement deficiencies and individuals receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis group B even after being vaccinated with BEXSERO
- Vaccination with BEXSERO may not result in protection in all vaccine recipients
WHAT ARE THE POTENTIAL SIDE EFFECTS?
The most common side effects associated with BEXSERO are:
- pain, redness or hardness at the injection site
- muscle pain
- joint pain
TELL YOUR HEALTHCARE PROFESSIONAL:
- if you are pregnant, plan to become pregnant, or are breastfeeding. BEXSERO should be used during pregnancy only if clearly needed
- if you experience an allergic reaction after a dose of BEXSERO
ADDITIONAL IMPORTANT INFORMATION
- It is unknown if BEXSERO can be given with other recommended adolescent vaccines
- It is unknown if BEXSERO is safe and effective in children younger than 10 years of age or adults older than 65 years of age
Ask your healthcare professional about all the risks and benefits of BEXSERO. Only a healthcare professional can decide if BEXSERO is right for you or your child.